COMMUNIQUÉS West-GlobeNewswire

DBV Technologies to Attend Upcoming Investor Conferences
01/09/2017
Press Release Montrouge, France, September 1, 2017 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced that members [...]
DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs
01/09/2017
Communiqué de Presse Montrouge, France, 1 Septembre 2017, 7h30 CEST DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : [...]
ONCURIOUS NV acquires unique portfolio of next-generation immuno-oncology assets from VIB
01/09/2017
Leuven, Belgium 1 September 2017 - ONCURIOUS NV, a Belgium-based biotech company focusing on the development of innovative oncology treatments, today announces that it has reached principle agreement with VIB to acquire [...]
Taconic Biosciences Sponsors Custom Model to Support Kabuki Syndrome, a Rare Disorder Causing Intellectual Disability
31/08/2017
HUDSON, N.Y., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered rodent models and associated services, is funding the development of a custom mouse model to study Kabuki [...]
NANOBIOTIX : Résultats semestriels au 30 juin 2017
31/08/2017
Résultats semestriels au 30 juin 2017 Paris, France, et Cambridge, Massachusetts (USA) le 31 août 2017 - NANOBIOTIX (Euronext : NANO - ISIN : FR0011341205), société française pionnière en nanomédecine développant de [...]
NANOBIOTIX half year results for the six months ended 30 June 2017
31/08/2017
Nanobiotix half year results for the six months ended 30 June 2017 Paris, France and Cambridge, Massachusetts, USA, August 31, 2017 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine [...]
EDAP Partners with Leading US HIFU provider, Vituro Health Adds Ablatherm Robotic HIFU
31/08/2017
Dr. S. Scionti, Medical Director of Vituro and most experienced HIFU urologist in the U.S. to start treating with Ablatherm in September LYON, France, August 31, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in [...]
AB Science annonce ses résultats semestriels au 30 juin 2017
31/08/2017
Paris, le 31 août 2017, 18h Perte nette de 13,5M€ au premier semestre 2017, en baisse de 8,4% par rapport au premier semestre 2016(14,7M€), en raison de la diminution des coûts de R&D Trésorerie de 49,3M€ au 30 juin [...]
AB Science reports its revenue for the first half of 2017
31/08/2017
Paris, August 31 2017, 6pm Net loss of 13.5M€ in the first half of 2017, a decrease of 8.4% as compared with the first half of 2016 (14.7M€), due to R&D costs decrease Cash position of 49.3M€ as of 30 June 2017, [...]
Summit Therapeutics plc : Half-yearly report
31/08/2017
Summit Therapeutics plc ('Summit', the 'Company' or the 'Group') SUMMIT THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER AND HALF YEAR ENDED 31 JULY 2017 AND OPERATIONAL PROGRESS Conference Call Scheduled [...]
Apricus Biosciences Announces FDA Acknowledgement of Vitaros(TM) Class 2 NDA Resubmission
31/08/2017
PDUFA Goal Date of February 17, 2018 SAN DIEGO, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today [...]
MPI: MPI publishes Half-year Report for the first half of 2017
31/08/2017
Hoersholm, Denmark, August 31, 2017 - Medical Prognosis Institute A/S ("MPI") announces the company's Half-year report for the period January-June 2017. The report is available as an attached document to this press [...]
Xbrane Biopharma releases interim report for the period April - June 2017
31/08/2017
Press release 2017-08-31 Xbrane Biopharma ABs interim report for the period April - June 2017 is now available on the Company's website, www.xbrane.com . April to June Net sales SEK 4,514 thousand (1,032) Total income [...]
Ambu A/S: Articles of Association August 2017
31/08/2017
Articles of Association August 2017 This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]
Ambu A/S: Capital increase in connection with exercise of warrants issued
31/08/2017
Company announcement no. 16_2016_17 This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]
Total number of shares and voting rights in Zealand at August 31, 2017
31/08/2017
Company announcement - No. 42 / 2017 Total number of shares and voting rights in Zealand at August 31, 2017 Copenhagen, August 31, 2017 - In accordance with Section 10 of the Danish Statutory Order on Issuers' [...]
Symphogen A/S: Symphogen presents promising results from a randomized Phase 2 study with Sym004 at ESMO 2017 Congress
31/08/2017
Symphogen presents promising results from a randomized Phase 2 study with Sym004 at ESMO 2017 Congress Oral presentation of efficacy and safety data of Sym004 in refractory metastatic colorectal cancer COPENHAGEN, [...]
ESPERITE (ESP): L1 Capital subscribes to the Seventh tranche of investment today
31/08/2017
Zutphen, The Netherlands, 31 August 2017 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the Seventh Tranche of EUR 250,000 is issued as a private placement of 25 convertible notes (the " [...]
Biocartis Group NV: Biocartis announces 2017 half-year results on 7 September 2017
31/08/2017
PRESS RELEASE - REGULATED INFORMATION Thursday, 31 August 2017, 07:01 CEST BIOCARTIS ANNOUNCES 2017 HALF-YEAR RESULTS ON 7 SEPTEMBER 2017 Mechelen, Belgium , 31 August 20 17 - Biocartis Group NV (the 'Company' or ' [...]

Pages